Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
G Musso, F Saba, M Cassader, R Gambino - Progress in Lipid Research, 2023 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting up to 30% of the
general adult population. NAFLD encompasses a histological spectrum ranging from pure …
general adult population. NAFLD encompasses a histological spectrum ranging from pure …
[HTML][HTML] Nutrition management in acute pancreatitis: Clinical practice consideration
Acute pancreatitis (AP) is a common gastrointestinal disease and the leading cause of
hospital admission and healthcare burden among gastrointestinal disorders in many …
hospital admission and healthcare burden among gastrointestinal disorders in many …
[HTML][HTML] Natural history and management of liver dysfunction in lysosomal storage disorders
MS Sarma, PR Tripathi - World Journal of Hepatology, 2022 - ncbi.nlm.nih.gov
Lysosomal storage disorders (LSD) are a rare group of genetic disorders. The major LSDs
that cause liver dysfunction are disorders of sphingolipid lipid storage [Gaucher disease …
that cause liver dysfunction are disorders of sphingolipid lipid storage [Gaucher disease …
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
N Cui, W Zhang, F Su, Z Zhang, B Li, D Peng… - Frontiers in …, 2023 - frontiersin.org
Bile acids are the main component of animal bile and are directly involved in the metabolic
process of lipids in vivo. Taurochenodeoxycholic acid (TCDCA) is the primary biologically …
process of lipids in vivo. Taurochenodeoxycholic acid (TCDCA) is the primary biologically …
[HTML][HTML] Genetically modified mouse models to study hepatic neutral lipid mobilization
G Haemmerle, A Lass - Biochimica et Biophysica Acta (BBA)-Molecular …, 2019 - Elsevier
Excessive accumulation of triacylglycerol is the common denominator of a wide range of
clinical pathologies of liver diseases, termed non-alcoholic fatty liver disease. Such …
clinical pathologies of liver diseases, termed non-alcoholic fatty liver disease. Such …
Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine
I Nalbantoglu, D Jain - Seminars in Diagnostic Pathology, 2019 - Elsevier
Cryptogenic cirrhosis (CC) is defined as cirrhosis of unknown etiology despite extensive
clinical, laboratory and pathologic work-up, and constitutes approximately 5–10% of all …
clinical, laboratory and pathologic work-up, and constitutes approximately 5–10% of all …
A novel mutation c. 153 C> A in a Tunisian girl with Wolman disease and unusual presentation: hemophagocytic lymphohistiocytosis
F Tinsa, MB Romdhane, H Boudabous… - Journal of pediatric …, 2019 - journals.lww.com
Wolman disease is an ultrarare lysosomal storage disease caused by a mutation in the LIPA
gene. The clinical features of Wolman disease include early onset of vomiting, diarrhea …
gene. The clinical features of Wolman disease include early onset of vomiting, diarrhea …
Pedigree Analysis of Nonclassical Cholesteryl Ester Storage Disease with Dominant Inheritance in a LIPA I378T Heterozygous Carrier
J Zhang, A Lin, L Zhang, D Ruan, M Gao… - Digestive Diseases and …, 2024 - Springer
Background Cholesterol ester storage disorder (CESD; OMIM: 278,000) was formerly
assumed to be an autosomal recessive allelic genetic condition connected to diminished …
assumed to be an autosomal recessive allelic genetic condition connected to diminished …
[HTML][HTML] Lysosomal acid lipase deficiency, a rare pathology: the first pediatric patient reported in Colombia
V Botero, VH Garcia, C Gomez-Duarte… - The American Journal …, 2018 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Lysosomal acid lipase deficiency is a rare genetic
metabolic lipid storage disease, with a high morbidity, and mortality, in children and adults. It …
metabolic lipid storage disease, with a high morbidity, and mortality, in children and adults. It …
[HTML][HTML] Cholesteryl ester storage disease of clinical and genetic characterisation: a case report and review of literature
EB Rashu, AE Junker, KV Danielsen… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Cholesteryl ester storage disease (CESD) is a rare genetic disease. Its
symptoms and severity are highly variable. CESD is a systemic disease that can lead to the …
symptoms and severity are highly variable. CESD is a systemic disease that can lead to the …